MyFinsight
Home
Blog
About
Proceeds from issuance of
common stock, net of...
$1,651,355K
Proceeds from issuance of
convertible senior notes,...
$487,068K
Proceeds from the sale of
future royalties, net...
$245,000K
Proceeds from issuance of
common stock under...
$28,844K
Proceeds from issuance of
common stock related to...
$8,473K
Proceeds from exercise of
warrants
$236K
Net cash provided by
financing activities
$2,420,485K
Canceled cashflow
$491K
Net increase
(decrease) in cash, cash...
$374,496K
Canceled cashflow
$2,045,989K
Deferred offering costs
$491K
Maturities of marketable
securities
$381,977K
Change in fair value of
warrant liability
$151,031K
Stock-based compensation
expense
$67,000K
Accrued expenses and
other current...
$55,783K
Non-cash interest
expense on liabilities...
$22,899K
Accounts payable
$5,031K
Depreciation and
amortization
$2,449K
Amortization of operating
lease right-of-use...
$2,051K
Non-cash interest
expense on convertible...
$880K
Net cash provided by
(used in) investing...
-$1,658,670K
Net cash used in
operating activities
-$387,319K
Canceled cashflow
$381,977K
Canceled cashflow
$307,124K
Purchases of marketable
securities
$2,038,361K
Net loss
-$644,371K
Purchases of property and
equipment
$2,286K
Prepaid expenses and
other current assets
$30,540K
Long-term deposits
$7,745K
Other noncurrent
liabilities
-$5,224K
Net amortization of
premium or discount on...
$4,333K
Operating lease liability
-$2,135K
Other prepaid and
noncurrent assets
-$95K
Back
Back
Cash Flow
Revolution Medicines, Inc. (RVMD)
Revolution Medicines, Inc. (RVMD)
source: myfinsight.com